Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The air–liquid interface (ALI) of the Eustachian tube mucosa is a specialized laboratory culture system used to simulate the physiological environment of the Eustachian tube in vitro (Jung et al., 2021, PubMed). In this model, epithelial cells are grown on a semi-permeable membrane where the basal surface is submerged in nutrient media and the apical surface is exposed to air. This configuration promotes the differentiation of a pseudostratified ciliated epithelium with mucus-secreting goblet cells, closely mimicking the in vivo state of the respiratory mucosa (Mather et al., 2019, NIH). This system is primarily used to study the pathophysiology of the Eustachian tube, including mucociliary clearance and the inflammatory response to pathogens like Streptococcus pneumoniae associated with otitis media. While it serves as a critical platform for testing the efficacy of surfactants, antibiotics, and anti-inflammatory agents, the interface itself is a biological model or experimental setup rather than a specific molecular drug target. It allows researchers to observe how the mucosal barrier interacts with environmental factors and pharmacological interventions in a controlled setting (Hehar et al., 2001, Journal of Laryngology & Otology). The model is essential for understanding Eustachian tube dysfunction, which is a primary contributing factor to middle ear diseases.
Not applicable as this is a tissue culture model/experimental system rather than a molecular therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Air–liquid interface of Eustachian tube mucosa (ET-ALI).